ARCHIVES

Randomized Trials Discovered Roles For Newly Approved Nexavar and Sutent.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

M.D. Anderson Must Evaluate 8 Patients In Controversial Study

May 31, 1996

Bypass Budget Omits Needless Words: Faster Progress to Cost $421 Million More

March 29, 1996

Femara Better Suppressor Of Estrogen, Study Finds

February 22, 2002

Roche Markets CMV Test in Europe

April 29, 2011

UCSD Cancer Center Breaks Ground for New Building

November 15, 2002

Budget Cuts Delay New Cooperative Drug Discovery Groups For Lung, Colon Cancer At Least One Year

February 21, 1986